BioLife Solutions (BLFS) Misses Q2 EPS by 2c ; Offers Guidance
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $34.97 +0.43%
Financial Fact:
Research and development: 496.87K
Today's EPS Names:
MTEX, NSYS, PLNH, More
Financial Fact:
Research and development: 496.87K
Today's EPS Names:
MTEX, NSYS, PLNH, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q2 EPS of ($0.23), $0.02 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $39.5 million versus the consensus estimate of $43.64 million.
GUIDANCE:
BioLife Solutions sees FY2023 revenue of $144-158 million, versus the consensus of $184.1 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance
- ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 13c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
